Literature DB >> 8810287

The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility.

T Grötzinger1, K Jensen, H Will.   

Abstract

Expression of the nuclear domain-associated proteins Sp100, PML, and NDP52, is enhanced by interferons (IFNs) on the mRNA and protein level. Increase both of Sp100 and PML mRNA is due to enhanced transcription of the corresponding genes which occurs independently of cellular protein synthesis immediately upon IFN-beta addition. Here, we describe the molecular cloning and functional analysis of the Sp100 promoter. DNA sequence analysis revealed potential binding sites for several constitutive and IFN-inducible transcription factors. Consistent with the absence of a TATA box and an initiator element, several transcription initiation sites were found. Transient expression studies identified an imperfect IFN-stimulated response element within the first 100 nucleotides upstream of the major transcription start site. This element rendered a heterologous promoter IFN-beta-inducible and bound IFN-stimulated gene factor 2 strongly but IFN-stimulated gene factor 3 only weakly. An IFN-gamma activation site approximately 500 base pairs upstream of the IFN-stimulated response element was found to bind three IFN-alpha/beta activation factors upon IFN-beta induction and conferred both type I and type II IFN inducibility upon a heterologous promoter. These data demonstrate a novel arrangement of a nonoverlapping IFN-gamma activation site and an IFN-stimulated response element mediating type I IFN inducibility, previously not reported for other IFN-stimulable promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810287     DOI: 10.1074/jbc.271.41.25253

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

3.  PML regulates PER2 nuclear localization and circadian function.

Authors:  Takao Miki; Zhixiang Xu; Misty Chen-Goodspeed; Mingguang Liu; Anita Van Oort-Jansen; Michael A Rea; Zhaoyang Zhao; Cheng Chi Lee; Kun-Sang Chang
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

4.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.

Authors:  Sonja Schmid; David Sachs; Benjamin R tenOever
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

6.  Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle.

Authors:  Nina Tavalai; Martina Adler; Myriam Scherer; Yvonne Riedl; Thomas Stamminger
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

7.  Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.

Authors:  P Muratori; L Muratori; F Cassani; P Terlizzi; M Lenzi; L Rodrigo; F B Bianchi
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

8.  A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.

Authors:  C Gongora; G Degols; L Espert; T D Hua; N Mechti
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

9.  Interferon activates promoter of Nmi gene via interferon regulator factor-1.

Authors:  Xiao Xu; Keli Chai; Yuhang Chen; Yongquan Lin; Suzhen Zhang; Xin Li; Wentao Qiao; Juan Tan
Journal:  Mol Cell Biochem       Date:  2017-09-14       Impact factor: 3.396

10.  Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.

Authors:  Ana V Chee; Pascal Lopez; Pier Paolo Pandolfi; Bernard Roizman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.